Aldeyra Therapeutics, Inc. (ALDX)

5.65 +0.12 (+2.17%) USD  |  NASDAQ  |  Feb 09, 11:12
More

Aldeyra Therapeutics SG&A Expense (TTM) : 9.186M for Sept. 30, 2025

SG&A Expense (TTM) Chart

View SG&A Expense (TTM) for ALDX.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View SG&A Expense (TTM) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

SG&A Expense (TTM) Range, Past 5 Years

View SG&A Expense (TTM) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

SG&A Expense (TTM) Benchmarks

View SG&A Expense (TTM) Benchmarks
Start Trial
Assertio Holdings, Inc. 63.52M
MediciNova, Inc. 5.882M
Altimmune, Inc. 22.68M
Actinium Pharmaceuticals, Inc. 15.79M
Avanos Medical, Inc. 316.50M